These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11726209)

  • 21. Altered methylation pattern of the G6 PD promoter in Rett syndrome.
    Huppke P; Bohlander S; Krämer N; Laccone F; Hanefeld F
    Neuropediatrics; 2002 Apr; 33(2):105-8. PubMed ID: 12075494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammalian methyl-binding proteins: what might they do?
    Joulie M; Miotto B; Defossez PA
    Bioessays; 2010 Dec; 32(12):1025-32. PubMed ID: 20886526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
    Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
    Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DamID, a new tool for studying plant chromatin profiling in vivo, and its use to identify putative LHP1 target loci.
    Germann S; Juul-Jensen T; Letarnec B; Gaudin V
    Plant J; 2006 Oct; 48(1):153-63. PubMed ID: 16972870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
    Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
    Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic regulation of cytomegalovirus major immediate-early promoter activity in transgenic mice.
    Mehta AK; Majumdar SS; Alam P; Gulati N; Brahmachari V
    Gene; 2009 Jan; 428(1-2):20-4. PubMed ID: 18976699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methyl CpG-binding proteins and transcriptional repression.
    Wade PA
    Bioessays; 2001 Dec; 23(12):1131-7. PubMed ID: 11746232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification of the MeCP2/histone deacetylase complex from Xenopus laevis.
    Jones PL; Wade PA; Wolffe AP
    Methods Mol Biol; 2001; 181():297-307. PubMed ID: 12843459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo cross-linking and immunoprecipitation for studying dynamic Protein:DNA associations in a chromatin environment.
    Kuo MH; Allis CD
    Methods; 1999 Nov; 19(3):425-33. PubMed ID: 10579938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profiling methyl-CpG specific determinants on transcriptionally silent chromatin.
    El-Osta A; Baker EK; Wolffe AP
    Mol Biol Rep; 2001; 28(4):209-15. PubMed ID: 12153140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CpG methylation, chromatin structure and gene silencing-a three-way connection.
    Razin A
    EMBO J; 1998 Sep; 17(17):4905-8. PubMed ID: 9724627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation.
    Fuks F; Hurd PJ; Wolf D; Nan X; Bird AP; Kouzarides T
    J Biol Chem; 2003 Feb; 278(6):4035-40. PubMed ID: 12427740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription.
    Yu F; Zingler N; Schumann G; Strätling WH
    Nucleic Acids Res; 2001 Nov; 29(21):4493-501. PubMed ID: 11691937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos.
    Stancheva I; Collins AL; Van den Veyver IB; Zoghbi H; Meehan RR
    Mol Cell; 2003 Aug; 12(2):425-35. PubMed ID: 14536082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin.
    Nan X; Campoy FJ; Bird A
    Cell; 1997 Feb; 88(4):471-81. PubMed ID: 9038338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation.
    Georgel PT; Horowitz-Scherer RA; Adkins N; Woodcock CL; Wade PA; Hansen JC
    J Biol Chem; 2003 Aug; 278(34):32181-8. PubMed ID: 12788925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromosomal regulation by MeCP2: structural and enzymatic considerations.
    Bowen NJ; Palmer MB; Wade PA
    Cell Mol Life Sci; 2004 Sep; 61(17):2163-7. PubMed ID: 15338046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of chromatin structure by in vivo formaldehyde cross-linking.
    Orlando V; Strutt H; Paro R
    Methods; 1997 Feb; 11(2):205-14. PubMed ID: 8993033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing of the mouse H-rev107 gene encoding a class II tumor suppressor by CpG methylation.
    Roder K; Latasa MJ; Sul HS
    J Biol Chem; 2002 Aug; 277(34):30543-50. PubMed ID: 12055182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.